Kneat.com, Inc.

TSX:KSI.TO

Medical - Healthcare Information Services

Healthcare
$6.50 -0.16%

-$0.01 today

Market cap
$624.86M
Beta
1.37
P/E (TTM)
-73.0
EPS (TTM)
-$0.09
52W Low $3.23High $6.44

Volume 0.10M

Average 0.31M

KSI.TO EBITDA Margin

EBITDA as a percentage of revenue.

Kneat.com, Inc.TSX: KSI.TO

EBITDA Margin · Q1 FY2026 · quarter ended Mar 2026

EBITDA Margin narrows to 8.9%

EBITDA Margin was 8.9% in Q1 FY2026, down 32.3 pp from a year earlier. On a trailing-twelve-month basis it was 19.0%, down 5.2 pp year over year. Over 3 fiscal years it widened by 22.3 pp.

Context

  • EBITDA Margin widened in 1 of the last 3 fiscal years.

What to watch

Whether EBITDA Margin reaches the consensus estimate from 5 analysts of 62.0% for the fiscal year ending Dec 2026, up from 8.8% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
8.9%-9.9 pp QoQ
Last fiscal yearDec 2025
8.8%-4.0 pp YoY
LTMMar 2026
19.0%-5.2 pp YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-32.3 pp+36.6 pp+68.8 pp
1 year-4.0 pp+53.2 pp+57.3 pp
3 years+22.3 pp+53.2 pp+31.0 pp
5 years——
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA Margin history

Percent of revenue · from the income statement

Latest · FY2025
8.8%
Year-over-year change
-4.0pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA Margin vs competitors

How KSI.TO compares with its peers on the latest reported figures

  • KSI.TO's LTM Mar 2026 EBITDA Margin of 19.0% is the 3rd highest of the 7 companies compared; the peer median is 7.9%.
  • Its year-over-year change of -5.2 pp is the 4th highest of 7, against a peer median of -1.0 pp.
  • Over three fiscal years its change of +22.3 pp compares with a peer median of +5.8 pp.
KSI.TO Competitors Peer median
EBITDA Margin for KSI.TO and competitors
Company Period LTM level YoY 3-year change
CPH.TOCipher Pharmaceuticals Inc.LTM Mar 202649.3% +16.9 pp-11.3 pp
VHI.TOVitalhub Corp.LTM Mar 202620.3% +3.9 pp+8.2 pp
KSI.TOKneat.com, Inc.LTM Mar 202619.0% -5.2 pp+22.3 pp
GUD.TOKnight Therapeutics Inc.LTM Mar 202612.8% -5.8 pp+3.5 pp
ACB.TOAurora Cannabis Inc.LTM Mar 20263.1% -11.9 pp+39.6 pp
WEED.TOCanopy Growth CorporationLTM Mar 2026-20.4% +157.8 pp+798.1 pp
EDT.TOSpectral Medical Inc.LTM Mar 2026-1275.3% -390.0 pp-37.5 pp
Peer median (excluding KSI.TO) 7.9%-1.0 pp+5.8 pp

Competitors are the stored peer set for KSI.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue15.5M23.75M34.22M48.94M63.26M
Cost of Revenue6.18M9.09M11.09M12.18M28.56M
Gross Profit9.32M14.65M23.13M36.76M34.7M
Gross Margin60.1%61.7%67.6%75.1%54.9%
Research & Development8.33M10.99M15.76M17.27M8.84M
Selling, General & Admin7.35M13.44M20.98M25.44M34.31M
Operating Expenses15.67M24.43M36.74M42.71M43.15M
Depreciation & Amortization4.44M5.7M7.61M10.13M13.99M
EBITDA(5.11M)(3.2M)(5.37M)6.27M5.54M
EBITDA Margin-33.0%-13.5%-15.7%12.8%8.8%
Operating Income(6.35M)(9.77M)(13.53M)(5.95M)(8.45M)
Operating Margin-41.0%-41.2%-39.5%-12.2%-13.4%
Interest Income6.45K2.75K6.64K678.39K516.74K
Interest Expense284.95K228.59K1.08M3.67M3.43M
Other Income / Expenses(3.48M)642.86K(529.44K)(1.59M)6.26M
Income Before Tax(9.84M)(9.13M)(14.06M)(7.53M)(2.19M)
Pre-Tax Margin-63.5%-38.5%-41.1%-15.4%-3.5%
Income Tax Expense20.91K16.61K55.89K192.6K158.86K
Net Income(9.86M)(9.15M)(14.12M)(7.73M)(2.35M)
Net Margin-63.6%-38.5%-41.3%-15.8%-3.7%
EPS (Basic)(0.13)(0.12)(0.18)(0.09)(0.02)
EPS (Diluted)(0.13)(0.12)(0.18)(0.09)(0.02)
Weighted Avg Shares74.11M77.44M77.83M86.55M94.91M
Weighted Avg Shares (Diluted)74.11M77.44M77.83M86.55M94.91M

Kneat.com, Inc.

TSX:KSI.TO

Intrinsic Alpha fair value

Locked

Current Price

$6.50

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.